Summary

The covid-19 vaccines may have provided health and economic benefits worth up to $64.3 trillion in the first year alone – almost double an earlier estimate. Previously, researchers calculated that the $79.4 billion invested in developing covid-19 vaccines saw a return of between $4.8 trillion and $37.9 trillion globally in the first 12 months after their rollout. But now, a reanalysis of the data suggests it is actually between $6.43 trillion and $64.3 trillion.

AI summaries can be wrong sometimes—always verify important details using the source article.